TP53 and neoplasm: Deregulation of common oncogenes (e.g. c-Myc, PIK3CA, Ras and Raf) and loss of common tumour suppressors (e.g. p53, PTEN and SWI/SNF) are associated with deregulated or enhanced gene expression.